MENU life more humann.SM Drawing on the legacy of innovator and humanitarian Alfred E. Mann, our team of passionate scientists, researchers, and professionals develops cutting-edge therapeutic products and technologies that help people take control of their health and live—fully humann. about us pipeline Our research and development pipeline is full of potential pathways to a world without limit for all. explore our pipeline patients Learn about our treatment option for patients with type 1 and type 2 diabetes, utilizing our needle-free, inhaled Technosphere® Technology, and the support we offer for patients with a prescription. Full Prescribing Information, including BOXED WARNING, Instructions for Use, and Medication Guide can be accessed at afrezza.com. support options discover afrezza® news & events view all news PreviousNext NOVEMBER 9, 2021 MannKind Corporation Reports 2021 Third Quarter Financial Results Conference Call to Begin Today at 5:00 p.m. (ET) 3Q 2021 Total Revenues of $22.2 million ; +45% vs. 3Q 2020 3Q 2021 Afrezza Net Revenue of $9.8 million ; + ... read more NOVEMBER 9, 2021 Mannkind Corporation Closes Sale-Leaseback Transaction Generating $102.25 Million in Non-Dilutive Gross Proceeds WESTLAKE VILLAGE, Calif. and DANBURY, Conn. , Nov. 09, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) , a company focused on the development ... read more partnering Leveraging our breakthrough therapies and technologies, we can help people get the most out of life—together. what we offer investors Our therapeutic innovations are empowering people to take control of their health and get the most out of life. investor information careers Work with passion, with purpose, with people on a mission to make the world a little more humann for all. life at MannKind Make a humann connection with us. Reach out anytime. MannKind Corporation 30930 Russell Ranch Road, Suite 300 Westlake Village, CA 91362 USA contact@mannkindcorp.com 818.661.5000 sign up for email updates Terms of Use Privacy Policy Patent Notices Corporate Governance ©2021 MannKind Corporation. All rights reserved.